Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 19.38 |
| Open | 20.13 |
| Bid | 20.03 x 100 |
| Ask | 20.12 x 200 |
| Day's Range | 19.63 - 20.40 |
| 52 Week Range | 12.94 - 22.09 |
| Volume | |
| Avg. Volume | 390,162 |
| Market Cap | 1.424B |
| Beta (5Y Monthly) | 0.30 |
| PE Ratio (TTM) | 154.46 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report
It's been a good week for Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) shareholders, because the company has just...
- Simply Wall St.
Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) First Quarter 2024 Results Key Financial Results Revenue: US$79.9m (up 65% from...
- Insider Monkey
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
© 2024 Yahoo. All rights reserved.